ANDROBIOSYS
AndroBioSys, Inc. (ABS), is a biotechnology company dedicated to the development of novel treatments for prostate disease. Based on technologies developed at Roswell Park Cancer Institute, AndroBioSys is pioneering new approaches to make treatment of prostate cancer curative, not palliative. Preventing progression of prostate disease is intertwined intimately with disruption of the androgen axis. ABS performs contract research screening services for academic, biotechnology and pharmaceutical clients and develops collaborative partnerships to discover new drugs to proprietary prostate disease targets.
ANDROBIOSYS
Industry:
Biotechnology Health Care Life Science Therapeutics
Founded:
2005-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.androbiosys.com
Total Employee:
1+
Status:
Closed
Contact:
7168453300
Total Funding:
500 K USD
Technology used in webpage:
InMotion Hosting InMotion Hosting DNS
Similar Organizations
AgeX Therapeutics
AgeX is a biotechnology company focused on the development of novel therapeutics for age-related degenerative disease.
Avogadro Development Corp
A clinical-stage biotechnology company focused on pattern recognition receptors in immunometabolic disease.
Nativis
Nativis is a biotechnology company that focuses on the development of therapeutic modalities for the treatment of serious disease.
Orpheus Bioscience
Orpheus Bioscience is a privately-held biotech company that develops novel treatments for autoimmune diseases.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Employees Featured
Founder
Investors List
Western New York Venture Association
Western New York Venture Association investment in Venture Round - AndroBioSys
Erie County Industrial Development Agency
Erie County Industrial Development Agency investment in Venture Round - AndroBioSys
Excell Partners
Excell Partners investment in Venture Round - AndroBioSys
